Virtus ETF Advisers’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,216
| Closed | -$38.6K | – | 442 |
|
|
2023
Q3 | $38.6K | Sell |
18,216
-1,809
| -9% | -$3.84K | 0.02% | 421 |
|
|
2023
Q2 | $95.3K | Buy |
20,025
+13,440
| +204% | +$64K | 0.06% | 406 |
|
|
2023
Q1 | $37.5K | Sell |
6,585
-2,528
| -28% | -$14.4K | 0.02% | 439 |
|
|
2022
Q4 | $92K | Buy |
9,113
+3,506
| +63% | +$35.4K | 0.05% | 441 |
|
|
2022
Q3 | $126K | Buy |
5,607
+41
| +0.7% | +$921 | 0.05% | 385 |
|
|
2022
Q2 | $138K | Buy |
5,566
+2,475
| +80% | +$61.4K | 0.05% | 333 |
|
|
2022
Q1 | $120K | Sell |
3,091
-183
| -6% | -$7.1K | 0.05% | 269 |
|
|
2021
Q4 | $192K | Buy |
3,274
+918
| +39% | +$53.8K | 0.07% | 223 |
|
|
2021
Q3 | $140K | Sell |
2,356
-130
| -5% | -$7.73K | 0.06% | 352 |
|
|
2021
Q2 | $216K | Sell |
2,486
-624
| -20% | -$54.2K | 0.09% | 285 |
|
|
2021
Q1 | $256K | Buy |
3,110
+49
| +2% | +$4.03K | 0.11% | 282 |
|
|
2020
Q4 | $278K | Sell |
3,061
-6,967
| -69% | -$633K | 0.12% | 249 |
|
|
2020
Q3 | $401K | Sell |
10,028
-1,361
| -12% | -$54.4K | 0.21% | 170 |
|
|
2020
Q2 | $391K | Sell |
11,389
-7,746
| -40% | -$266K | 0.19% | 205 |
|
|
2020
Q1 | $425K | Sell |
19,135
-2,782
| -13% | -$61.8K | 0.17% | 191 |
|
|
2019
Q4 | $429K | Buy |
21,917
+7,741
| +55% | +$152K | 0.07% | 234 |
|
|
2019
Q3 | $220K | Sell |
14,176
-789
| -5% | -$12.2K | 0.04% | 233 |
|
|
2019
Q2 | $304K | Sell |
14,965
-1,647
| -10% | -$33.5K | 0.06% | 206 |
|
|
2019
Q1 | $292K | Sell |
16,612
-1,728
| -9% | -$30.4K | 0.62% | 61 |
|
|
2018
Q4 | $235K | Sell |
18,340
-19,754
| -52% | -$253K | 0.04% | 168 |
|
|
2018
Q3 | $621K | Sell |
38,094
-27,979
| -42% | -$456K | 0.06% | 95 |
|
|
2018
Q2 | $749K | Buy |
+66,073
| New | +$749K | 0.66% | 71 |
|